Table 2.
OR | 95% CI | P value | |
All patients | |||
Age | 0.995 | 0.979 to 1.011 | 0.551 |
Arterial hypertension | 0.747 | 0.473 to 1.180 | 0.211 |
Diabetes mellitus | 1.412 | 0.874 to 2.280 | 0.159 |
Ischaemic aetiology | 1.961 | 1.128 to 3.410 | 0.017 |
Decompensation factor | 0.855 | 0.573 to 1.277 | 0.444 |
LV ejection fraction | 0.978 | 0.955 to 1.002 | 0.072 |
RV dysfunction | 1.359 | 0.890 to 2.076 | 0.155 |
Admission data: | |||
SBP | 0.985 | 0.975 to 0.995 | 0.003 |
Heart rate | 0.996 | 0.987 to 1.005 | 0.364 |
BNP | 1.215 | 1.040 to 1.420 | 0.014 |
Blood urea | 1.003 | 0.999 to 1.007 | 0.109 |
Inotropic drug use | 10.628 | 5.055 to 22.344 | <0.001 |
Patients treated with inotropics | |||
Age | 1 | 0.982 to 1.017 | 0.967 |
Arterial hypertension | 0.701 | 0.423 to 1.161 | 0.168 |
Diabetes mellitus | 1.378 | 0.813 to 2.334 | 0.234 |
Ischaemic aetiology | 1.992 | 1.091 to 3.635 | 0.025 |
Decompensation factor | 0.95 | 0.614 to 1.471 | 0.819 |
LV ejection fraction | 0.975 | 0.950 to 1.002 | 0.067 |
RV dysfunction | 1.526 | 0.964 to 2.417 | 0.071 |
Admission data: | |||
SBP | 0.986 | 0.975 to 0.996 | 0.008 |
Heart rate | 0.99 | 0.981 to 1.000 | 0.044 |
BNP | 1.193 | 1.009 to 1.411 | 0.039 |
Blood urea | 1.002 | 0.998 to 1.005 | 0.436 |
Association of inotropes | 5.524 | 2.692 to 11.335 | <0.001 |
BNP, B natriuretic peptide; LV, left ventricle; RV, right ventricle; SBP, systolic blood pressure.